June 18, 2025 05:02 PM GMT Medical Technology | North America Off the Beaten Path In this note we flag each week a handful of news drops that we think may have been missed / piqued our interest. [EW, MDT] Real-World Data in EMEA Favoring SAVR vs. TAVR In Younger Patients: A new study in Italy suggests that SAVR may be associated with more favorable mortality outcomes in intermediate surgical risk patients than TAVR, with curves decently below from about 1 year onwards (see below), which in theory is negativ ...

Flexible Solutions International (FSI) Q1 2025 Earnings Call May 16, 2025 11:00 AM ET Company Participants Daniel O’Brien - CEO & DirectorWilliam Gregozeski - President & Director of ResearchTim Clarkson - Stock Broker Conference Call Participants Manny Stoupakis - Research AnalystNone - Analyst Operator Good day, everyone, and welcome to today's Flexible Solutions International's First Quarter twenty twenty five Financials Conference Call. Please note this call is being recorded, and I'll be standing by if ...

Financial Data and Key Metrics Changes - Sales for Q1 2025 decreased by 19% compared to Q1 2024, amounting to $7.47 million versus $9.22 million [18] - Q1 2025 profits resulted in a loss of $278,000 or $0.02 per share, compared to a gain of $457,000 or $0.04 per share in Q1 2024 [19] - Operating cash flow for Q1 2025 was $480,000 or $0.04 per share, down from $1.38 million or $0.11 per share in 2024 [20] Business Line Data and Key Metrics Changes - The NanoChem division (NCS) accounts for approximately 70% of total revenue, focusing on biodegradable polymers and nitrogen conservation products [4] - The E and P division, which targets greenhouse turf and golf markets, is expected to see growth in the second half of 2025 [11] - The food division's sales are projected to grow in 2025, contingent on the production timeline of a new food-grade product [13] Market Data and Key Metrics Changes - Agricultural products in the US are under pressure, with crop prices not increasing at the rate of inflation, leading to uncertainty due to tariff changes [12] - Current tariffs on imports of raw materials from China range between 30% to 58.5%, impacting cost structures [13] Company Strategy and Development Direction - The company is developing a duplicate agriculture and polymer factory in Panama to reduce exposure to US tariffs and improve shipping efficiency [14][15] - The strategy includes moving most agriculture and polymer production to Panama, allowing the Illinois plant to focus on food-grade production [16] - The company aims to achieve significant revenue from the new food-grade contract, with a target of $30 million per year in the next four to six quarters [9] Management's Comments on Operating Environment and Future Outlook - Management expects Q2 2025 results to improve compared to Q1 2025, with anticipated resolution of inventory reductions by large customers [19][35] - The company is cautious about the impact of rising costs and low crop prices on sales, particularly due to political actions and tariffs [12] - Management believes that lower oil prices could positively affect raw material and shipping costs, potentially increasing margins [49] Other Important Information - The company has sufficient cash flow and working capital to execute its plans without the need for debt or equity financing [21][22] - Long-term debt is being paid down, with significant cash flow expected to be freed up in the coming years [21] Q&A Session Summary Question: Financial responsibility for clean room construction - The company is solely responsible for the clean room capital expenditures, while the client contributes to equipment costs [24] Question: Expectations on margins for new food business - Margins are expected to be stable and tied to inflation, with a set pricing equation agreed upon with the client [25][26] Question: Impact of high tariff products on margins - The company did not purchase high tariff raw materials, mitigating potential margin hits [29] Question: Expectations for sustained operating expenses post-expansion - Continuous cost increases are anticipated, particularly for accounting and software upgrades due to new complex products [31] Question: Future dividend policy - A regular dividend is possible but would be small to ensure sustainability during uncertain events [33] Question: Anticipated improvements in Q2 results - Management expects Q2 results to be better than Q1 [35] Question: Risks associated with new contract execution - Risks include equipment and clean room timing, but management is confident in execution capabilities [36] Question: Rationale for shifting manufacturing to Panama - The decision was influenced by previous tariff impacts and the need for a competitive international production site [39][40] Question: Potential food deals in the pipeline - The company has potential deals but cannot disclose details due to contractual constraints [47] Question: Relationship between oil prices and business - Lower oil prices could lead to reduced raw material and shipping costs, potentially benefiting margins [49]

Financial Data and Key Metrics Changes - Revenue for 2024 was flat compared to 2023, at $38.23 million versus $38.32 million [35] - Profits for 2024 were $3.04 million or $0.24 per share, compared to $2.78 million or $0.22 per share in 2023 [35] - Operating cash flow for 2024 was $7.08 million or $0.57 per share, up from $4.60 million or $0.37 per share in 2023 [36] Business Line Data and Key Metrics Changes - The NanoChem division (NCS) represents approximately 70% of total revenue, focusing on biodegradable polymers and agricultural products [5][6] - The ENP division focuses on sales into greenhouse, turf, and golf markets, with mild growth expected to continue in 2025 [14][15] - The food division is projected to grow in 2025, depending on the production timeline of new products [20] Market Data and Key Metrics Changes - Agricultural products in the US are selling reasonably well, but crop prices are not increasing at the rate of inflation [18] - Tariffs on raw materials imported from China have negatively impacted costs, cash flow, and profits [21] - The company is developing a new facility in Panama to mitigate tariff impacts and improve operational efficiency for international sales [24][25] Company Strategy and Development Direction - The company is focusing on expanding its food-grade product line and has secured a significant food-grade contract, requiring new equipment and clean room installations [9][10] - A new production facility in Panama is expected to begin operations in Q3 2025, which will reduce tariff exposure and improve shipping logistics [24][26] - The company is exploring entry into the drug compounding industry, with plans to secure sales before further investments [31][32] Management's Comments on Operating Environment and Future Outlook - Management anticipates a return to growth in 2025, particularly in the second half of the year [34] - The company is optimistic about its positioning to grow despite uncertainties related to the new administration [34] - Management highlighted challenges in finalizing new orders, including the need for equipment installation and customer satisfaction with pricing [48] Other Important Information - The company has substantial cash on hand and does not anticipate needing equity financing for upcoming capital expenditures [10] - The company has hired a consulting group to assist in obtaining export rebates for tariffs, which have been difficult to recover [22] Q&A Session Summary Question: What is the deal with Panama and tariffs? - The tariffs in Panama are much lower than those in the US, allowing for reduced friction in operations [43] Question: Expected gross margins on new food business contracts? - Margins are uncertain but expected to be in the same range as historical margins [44][45] Question: What are the challenges in finalizing orders? - Challenges include building new clean rooms, installing equipment, and proving scalability to customers [48] Question: Is the new product a proprietary development? - The new product is proprietary to the customer, and the company is adapting its operations to manufacture it [52][54] Question: What sets the company apart in securing this business? - The company has demonstrated high-quality operations and a willingness to invest in changes to earn the business [56][57]